<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897646</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0082</org_study_id>
    <nct_id>NCT04897646</nct_id>
  </id_info>
  <brief_title>The TELEAP1 CPAP-telemonitoring Study</brief_title>
  <acronym>TELEAP1</acronym>
  <official_title>Evaluation of a CPAP Telemonitoring Algorithm for Newly Treated Patients: the TELEAP1 Multicenter Cohort Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ADENE, Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AGIR à dom, Meylan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ASTEN sante, Pays de la Loire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ELIA medical, Cesson-Sévigné</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TELEAP1 is a multicenter cohort pilot-study designed to evaluate the impact of a published&#xD;
      SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm on the CPAP-compliance of&#xD;
      newly treated patients with obstructive sleep apnea..&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continuous Positive Airway Pressure (CPAP)-devices can track compliance, but also leaks and&#xD;
      residual Apnea-Hypopnea-Index (AHIflow) values. CPAP tracking systems seem intuitively&#xD;
      useful, but there are few data demonstrating the benefit of such systems in improving&#xD;
      CPAP-compliance and/or patients quality of life.&#xD;
&#xD;
      In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil&#xD;
      (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a&#xD;
      CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with&#xD;
      obstructive sleep apnea.&#xD;
&#xD;
      In order to describe and evaluate the impact of this SFRMS/SPLF-algorithm (not only on the&#xD;
      patient but also on the home care provider activity), a one year multicenter cohort&#xD;
      pilot-study (TELAP1-study) was set up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CPAP-complianceversus corresponding 2019 weeks (h/days)</measure>
    <time_frame>4 months</time_frame>
    <description>CPAP-compliance (hour/day) reported by the CPAP-software for the last 28 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AHIflow</measure>
    <time_frame>4 months</time_frame>
    <description>AHIflow (events/hour) reported by the CPAP-software for the last 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-adherence</measure>
    <time_frame>12 months</time_frame>
    <description>CPAP-adherence defined as the % of patients with a CPAP-adherence &gt;4h/day, CPAP-adherence reported by the CPAP-software for the last 28 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-leaks</measure>
    <time_frame>4 months</time_frame>
    <description>important leaks (l/min or % or min/days) reported by the CPAP-software for the last 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-leaks</measure>
    <time_frame>12 months</time_frame>
    <description>important leaks (l/min or % or min/days) reported by the CPAP-software for the last 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient subjective sleepiness</measure>
    <time_frame>4 months</time_frame>
    <description>reported by the patient using the Epworth Sleepiness Scale (0-24)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient subjective sleepiness</measure>
    <time_frame>12 months</time_frame>
    <description>reported by the patient using the Epworth Sleepiness Scale (0-24)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient subjective depression</measure>
    <time_frame>12 months</time_frame>
    <description>reported by the patient using the Pichot Depression Scale (0-13)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient subjective insomnia</measure>
    <time_frame>4 months</time_frame>
    <description>reported by the patient using the Insomnia Severity Scale (0-28)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient subjective insomnia</measure>
    <time_frame>12 months</time_frame>
    <description>reported by the patient using the Insomnia Severity Scale (0-28)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-compliance</measure>
    <time_frame>12 months</time_frame>
    <description>CPAP-compliance (hour/day) reported by the CPAP-software for the last 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned patient phone call</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>unplanned patient phone call with the technician regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned technician phone call</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>unplanned technician phone call with the patient regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned patient visit</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>unplanned patient visit to the care provider regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned technician visit</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>unplanned technician visit to the patient regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP telemonitoring alarm</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>number and type (cpap observance &lt; 4h for the last 7 days, and or IAHflow &gt;10/h for the last 7 days, and or important leaks for the last 7 days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interface-type change</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>description of the interface-type change (nasal, nasal pillows, oronasal) regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure settings modification</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>Change in the CPAP-pressure settings regardless of the reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP-mode modification</measure>
    <time_frame>Day 0 to 360</time_frame>
    <description>Change in the CPAP mode (constant or auto-CPAP) regardless of the reason</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm.</intervention_name>
    <description>In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with obstructive sleep apnea.&#xD;
The algorithm is exhasutively described in the following published article: Prigent, A., Gentina, T., Launois, S., et al. [Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal]. Rev. Mal. Respir., 2020, 37: 550-560.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients included in the study are newly CPAP-treated with a diagnosis of obstructive sleep&#xD;
        apnea.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Patient newly CPAP-treated and eligible for care and for the reimbursement by the&#xD;
             French Social Security rules&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Previous CPAP-treatment&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability to understand the nature and aims of the study or to communicate with the&#xD;
             investigator&#xD;
&#xD;
          -  Simultaneous participation in another trial with an exclusion clause to participate in&#xD;
             another trial&#xD;
&#xD;
          -  No affiliation with the French social security regime&#xD;
&#xD;
          -  Loss of personal capacity resulting in state protection&#xD;
&#xD;
          -  Deprivation of liberty by judicial or administrative decision&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dany Jaffuel, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montpellier University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fréderic Gagnadoux</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaud Prigent</last_name>
    <role>Principal Investigator</role>
    <affiliation>Polyclinique Saint Laurent - Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Renaud Tamisier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dany Jaffuel, MD, PhD</last_name>
    <phone>+33467314840</phone>
    <email>dany.jaffuel@wanadoo.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnaud Prigent, MD</last_name>
    <email>a.prigent@stv-stlaurent.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dany Jaffuel, MD, PhD</last_name>
      <phone>4 67 33 63 03</phone>
      <phone_ext>33</phone_ext>
      <email>dany.jaffuel@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive Sleep apnea</keyword>
  <keyword>Continuous Positive Airway Pressure,</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>COVID 19</keyword>
  <keyword>observance</keyword>
  <keyword>leaks</keyword>
  <keyword>apnea hypopnea index.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

